SCHEMBL23964401

SCHEMBL23964401

Cc1ccc2c(c1)/C(=C/c1cc(Br)c(O)c(Br)c1)C(=O)N2

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 11/20 0.73
LRRK2 Q5S007 5/20 0.73
MAP1LC3B Q9GZQ8 3/20 0.73
PSEN1 P49768 1/20 0.73
PSEN2 P49810 1/20 0.73
APH1B Q8WW43 1/20 0.73
NCSTN Q92542 1/20 0.73
APH1A Q96BI3 1/20 0.73
PSENEN Q9NZ42 1/20 0.73
EGFR P00533 1/20 0.73
NTRK1 P04629 1/20 0.73
ARAF P10398 1/20 0.73
PIM1 P11309 1/20 0.73
BRAF P15056 1/20 0.73
CSNK2A1 P68400 1/20 0.73
PIM3 Q86V86 1/20 0.73
SIRT2 Q8IXJ6 1/20 0.73
SIRT1 Q96EB6 1/20 0.73
MYOC Q99972 1/20 0.73
DYRK4 Q9NR20 1/20 0.73

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7742169 1.00 RAF1 (0.73) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL5774039 0.86 MAP1LC3B (0.88) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL5774043 0.86 MAP1LC3B (0.88) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL3754416 0.86 MAP1LC3B (0.88) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL19392080 0.85 PLK4 (0.73) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL5771599 0.84 RAF1 (0.73) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL7982725 0.84 RAF1 (0.73) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL1395354 0.84 LRRK2 (1.00) RAF1LRRK2MAP1LC3BPSEN1PSEN2
Gw305074X SCHEMBL12199472 0.84 RAF1 (1.00) RAF1LRRK2MAP1LC3BPSEN1PSEN2
SCHEMBL3800644 0.84 LRRK2 (1.00) RAF1LRRK2MAP1LC3BPSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223770-A2 NOVEL FUSION MOLECULES AND USES THEREOF Foundation Medicine, Inc. (US) 2023-08-09 EP disclosed
WO-2021213518-A1 COMPOUND FOR PREVENTING OR TREATING LIPID METABOLISM-RELATED DISEASES 复旦大学 (CN) 2021-10-28 WO disclosed